XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Common stock, shares, beginning balance at Dec. 31, 2023   106,847,000      
Stockholders' equity, beginning balance at Dec. 31, 2023 $ 6,687,469 $ 107 $ 2,890,427 $ 3,971,066 $ (174,131)
Net income 236,616     236,616  
Other comprehensive income (loss) (9,474)       (9,474)
Common stock issued for share-based compensation, shares   316,000      
Common stock issued for share-based compensation 0 $ 0 0    
Tax withholding related to vesting of restricted stock, shares   (122,000)      
Tax withholding related to vesting of restricted stock (18,952) $ 0 (18,952)    
Share-based compensation expense 6,855   6,855    
Common stock, shares, ending balance at Mar. 31, 2024   107,041,000      
Stockholders' equity, ending balance at Mar. 31, 2024 $ 6,902,514 $ 107 2,878,330 4,207,682 (183,605)
Common stock, shares, beginning balance at Dec. 31, 2024 107,060,281 107,060,000      
Stockholders' equity, beginning balance at Dec. 31, 2024 $ 7,977,577 $ 107 2,898,418 5,263,110 (184,058)
Net income 209,535     209,535  
Other comprehensive income (loss) 12,990       12,990
Common stock issued for share-based compensation, shares   284,000      
Common stock issued for share-based compensation 0 $ 0 0    
Tax withholding related to vesting of restricted stock, shares   (100,000)      
Tax withholding related to vesting of restricted stock (15,421) $ 0 (15,421)    
Share-based compensation expense $ 2,653   2,653    
Common stock, shares, ending balance at Mar. 31, 2025 107,244,215 107,244,000      
Stockholders' equity, ending balance at Mar. 31, 2025 $ 8,187,334 $ 107 $ 2,885,650 $ 5,472,645 $ (171,068)